Clinical commissioning groups (CCGs) will now be monitored on access to cancer diagnostics.
A range of new indicators from the National Institute for Health and Care Excellence (NICE) aim to improve access to scans for ovarian and colorectal cancers.
The indicators will measure how many women with raised CA125 levels have an ultrasound within two weeks and how many colorectal cancer patients have diagnostic colonoscopy.
Clinical commissioning groups (CCGs) will now be monitored on access to cancer diagnostics.
A range of new indicators from the National Institute for Health and Care Excellence (NICE) aim to improve access to scans for ovarian and colorectal cancers.
The indicators will measure how many women with raised CA125 levels have an ultrasound within two weeks and how many colorectal cancer patients have diagnostic colonoscopy.
The measures have been proposed as part of the consultation into 28 indicators suggested for the 2015/16 CCG outcomes indicator set.
The consultation closes on March 3, and a final indicator set will be sent to NHS England for approval.
